Radiation products maker
Varian Medical Systems
said second-quarter profit rose 3% from a year ago, helped by strong sales of its oncology systems and X-ray products.
The Palo Alto, Calif.-based company earned $55.8 million, or 41 cents a share, compared with $54.2 million, or 39 cents a share, a year ago. After adjusting for stock option expenses, the company earned 46 cents a share in the quarter, in line with the analysts' forecast.
Revenue was $413.9 million in the quarter, up 18%. The Wall Street estimate was $402.4 million.
Revenue at the company's oncology systems rose 18% to $346 million while X-ray products earnings increased 21% to $61 million.
The company expects its third-quarter earnings a share to grow about 14%, excluding stock option expenses of 5 cents a share. Sales are expected to grow in the low double digits from last year.
For the full year, the company forecasts earnings a share to grow by 17% to 18%, excluding option expenses of 19 cents a share to 22 cents a share. The company sees full year revenue growth of 14%.
"The second quarter was marked by strong revenue growth in our Oncology Systems and X-Ray Products businesses with solid contributions from some of our emerging businesses in brachytherapy and flat-panel digital image detectors for filmless X-rays," the company said.
The company's stock was trading at $51.70, down $1.20.
This story was created through a joint venture between TheStreet.com and IRIS.